Your browser doesn't support javascript.
loading
Health state utilities associated with hyperphagia: Data for use in cost-utility models.
Howell, Timothy A; Matza, Louis S; Mallya, Usha G; Goldstone, Anthony P; Butsch, W Scott; Lazarus, Ethan.
Afiliação
  • Howell TA; Patient-Centered Research Evidera Bethesda Maryland USA.
  • Matza LS; Patient-Centered Research Evidera Bethesda Maryland USA.
  • Mallya UG; Value and Evidence Rhythm Pharmaceuticals, Inc Boston Massachusetts USA.
  • Goldstone AP; PsychoNeuroEndocrinology Research Group Division of Psychiatry Department of Brain Sciences Imperial College London London UK.
  • Butsch WS; Department of Endocrinology Imperial College Healthcare NHS Trust Hammersmith Hospital London UK.
  • Lazarus E; Bariatric and Metabolic Institute Cleveland Clinic Cleveland Ohio USA.
Obes Sci Pract ; 9(4): 376-382, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37546284
Objective: Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels. Methods: Four health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample. Results: In total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia. Conclusions: These data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article